Verition Fund Management LLC Ocular Therapeutix, Inc Transaction History

Verition Fund Management LLC

  • $16.5 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$4.6 - $7.64 $252,769 - $419,818
54,950 New
54,950 $283,000
Q4 2022

Feb 14, 2023
BUY
$2.61 - $4.41 $18,982 - $32,073
7,273 Added 71.1%
17,502 $49,000
Q2 2022

Aug 15, 2022
BUY
$3.01 - $5.22 $689 - $1,195
229 Added 2.29%
10,229 $41,000
Q4 2021

Feb 14, 2022
BUY
$6.16 - $12.07 $61,600 - $120,700
10,000 New
10,000 $70,000

Others Institutions Holding OCUL

# of Institutions
151
Shares Held
136M
Call Options Held
86.4K
Put Options Held
263K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $668M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email